Cencora, Inc. SG&A Expense 2007-2026 | COR
Beta
What is sg&a expense?
Selling, general, and administrative expenses include all non-production costs such as marketing, corporate overhead, and management salaries.
What is Cencora, Inc.'s current sg&a expense?
Cencora, Inc. (COR) annual sg&a expense for 2025 was $6.49B, a 14.71% increase from 2024. Cencora, Inc. sg&a expense for the quarter ending December 31, 2025 was $1.80B.
What was Cencora, Inc.'s sg&a expense in 2024?
Cencora, Inc. annual sg&a expense for 2024 was $5.66B, a 6.61% increase from 2023.
What was Cencora, Inc.'s sg&a expense in 2023?
Cencora, Inc. annual sg&a expense for 2023 was $5.31B, a 9.51% increase from 2022.
What is Cencora, Inc.'s 5-year sg&a expense CAGR?
Cencora, Inc. sg&a expense grew at a compound annual growth rate (CAGR) of 18.60% from FY2020 to FY2025, going from $2.77B to $6.49B over 5 years.
SG&A Expense History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+18.6%
FY2020
$2.77B
→
FY2025
$6.49B
07080910111213141516171819202122232425
5 years selected
SG&A Expense History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $6.49B | +14.7% | 10-K |
| FY2024 | $5.66B | +6.6% | 10-K |
| FY2023 | $5.31B | +9.5% | 10-K |
| FY2022 | $4.85B | +34.9% | 10-K |
| FY2021 | $3.59B | +29.9% | 10-K |
| FY2020 | $2.77B | +3.9% | 10-K |
| FY2019 | $2.66B | +8.3% | 10-K |
| FY2018 | $2.46B | +15.6% | 10-K |
| FY2017 | $2.13B | +1.8% | 10-K |
| FY2016 | $2.09B | +9.6% | 10-K |
| FY2015 | $1.91B | +20.7% | 10-K |
| FY2014 | $1.58B | +18.5% | 10-K |
| FY2013 | $1.33B | +15.7% | 10-K |
| FY2012 | $1.15B | +1.3% | 10-K |
| FY2011 | $1.14B | -1.1% | 10-K |
| FY2010 | $1.15B | +2.7% | 10-K |
| FY2009 | $1.12B | +0.1% | 10-K |
| FY2008 | $1.12B | -16.5% | 10-K |
| FY2007 | $1.34B | - | 10-K |
Company: Cencora, Inc.Ticker: CORSector: HealthcareIndustry: Wholesale-Drugs, Proprietaries & Druggists' SundriesView company profile →